B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS Pathogens 7.8 (2011)
- Schlagwort
-
-
Infektion
Infektiologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2012
- Beteiligte Personen und Organisationen
-
Pötzsch, Sonja
Spindler, Nadja
Wiegers, Anna-Katharina
Fisch, Tanja
Rücker, Pia
Sticht, Heinrich
Grieb, Nina
Baroti, Tina
Weisel, Florian
Stamminger, Thomas
Martin-Parras, Luis
Mach, Michael
Winkler, Thomas H.
- URN
-
urn:nbn:de:bvb:29-opus-31650
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pötzsch, Sonja
- Spindler, Nadja
- Wiegers, Anna-Katharina
- Fisch, Tanja
- Rücker, Pia
- Sticht, Heinrich
- Grieb, Nina
- Baroti, Tina
- Weisel, Florian
- Stamminger, Thomas
- Martin-Parras, Luis
- Mach, Michael
- Winkler, Thomas H.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2012
Ähnliche Objekte (12)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies : = Neue antigene Domänen für die Induktion von neutralisierenden Antikörpern auf Glykoprotein B des humanen Cytomegalovirus
Neutralizing antibodies as tools for structure-based vaccine design
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies : = Neue antigene Domänen für die Induktion von neutralisierenden Antikörpern auf Glykoprotein B des humanen Cytomegalovirus
Neutralizing antibodies as tools for structure-based vaccine design
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies : = Neue antigene Domänen für die Induktion von neutralisierenden Antikörpern auf Glykoprotein B des humanen Cytomegalovirus
Neutralizing antibodies as tools for structure-based vaccine design